The Multimorbidity Care Program was specifically developed to support in managing patients with multiple long-term conditions. Get to know the program in this replay of the Webinar targeted to Africa & Turkey and chaired by Prof. Kamlesh Khunti (UK).
In this replay, Prof. Claudio Borghi guides through the Asian Webinar introducing the Multimorbidity Care Program, which provides participants with the latest data and evidence-based clinical guidelines to manage patients with multiple long-term conditions.
The replay of the Latin American Webinar provides an introduction to the Multimorbidity Care Program, a six-module learning program supporting the management of patients with multiple long-term conditions.
Watch the replay of the European Webinar chaired by Prof. Juan Carlos Kaski (UK), providing an introduction to the Multimorbidity Care Program, a six-module learning program supporting the management of patients with multiple long-term conditions.
Take the educational program developed by leading global clinical experts providing the latest data and evidence-based clinical guidelines to help manage patients with multiple long-term conditions.
Adherence to treatment is a key issue in the management of cardiometabolic diseases. Watch the replay of the Cardiometabolic & Venous diseases Forum 2024 sessions discussing solutions to improve adherence.
This forum addresses the main challenges of cardiometabolic diseases and their possible solutions through a discussion with HCPs, companies, and regulatory affairs experts.
The webinar held in Spanish language will provide an overview and update on the management of hypertension in patients with cardiometabolic comorbidities.
Get updated on the holistic management of multimorbid patients in cardiometabolic diseases in this replay of the Cardiometabolic & Venous diseases Forum.
Get updated on the management of heart failure in this replay of the Cardiometabolic & Venous diseases Forum, including discussions on the treatment of HFrEF, SGLT2i, and how to implement ESC Guidelines.